Search Results - Julien Kirchgesner
- Showing 1 - 4 results of 4
-
1
Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis. by Julien Kirchgesner, Laurent Beaugerie, Fabrice Carrat, Harry Sokol, Jacques Cosnes, Michaël Schwarzinger, BERENICE Study Group
Published 2016-01-01
Article -
2
Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease. by Guillaume Le Gall, Julien Kirchgesner, Mohamed Bejaoui, Cécilia Landman, Isabelle Nion-Larmurier, Anne Bourrier, Harry Sokol, Philippe Seksik, Laurent Beaugerie
Published 2018-01-01
Article -
3
Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer by Aonghus Lavelle, Stéphane Nancey, Jean-Marie Reimund, David Laharie, Philippe Marteau, Xavier Treton, Matthieu Allez, Xavier Roblin, Georgia Malamut, Cyriane Oeuvray, Nathalie Rolhion, Xavier Dray, Dominique Rainteau, Antonin Lamaziere, Emilie Gauliard, Julien Kirchgesner, Laurent Beaugerie, Philippe Seksik, Laurent Peyrin-Biroulet, Harry Sokol
Published 2022-12-01
Article -
4
Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study by Harry Sokol, Cecilia Landman, Philippe Seksik, Laurence Berard, Mélissa Montil, Isabelle Nion-Larmurier, Anne Bourrier, Guillaume Le Gall, Valérie Lalande, Alexis De Rougemont, Julien Kirchgesner, Anne Daguenel, Marine Cachanado, Alexandra Rousseau, Élodie Drouet, Michelle Rosenzwajg, Hervé Hagege, Xavier Dray, David Klatzman, Philippe Marteau, Saint-Antoine IBD Network, Laurent Beaugerie, Tabassome Simon
Published 2020-02-01
Article